The Week Ahead: Lloyds Bank, Shell, Centrica, BT, Vodafone
22nd July 2022 11:09
by Richard Hunter from interactive investor
Share on
Results continue to flow in the coming days, with all the big UK banks publishing new numbers, plus a host of other FTSE 100 firms. Earnings reports come thick and fast in the US, too. Our head of markets talks through events for your diary next week.
- UK bank sector results season: these are the likely winners
- US results season preview Q2 2022: banks and energy in focus
- 12 stocks for dividend investors hunting for high yields
- Dividend yield: three tips to help build your investment wealth
- Funds Fan: winners and losers so far in 2022, and why small-caps outperform
Monday 25 July
Trading statements
ECO Animal Health Group, F&C Investment Trust, GlobalData, JTC, Plant Health Care, SThree, Vodafone Group (LSE:VOD), XLMedia
AGM/EGM
BP Marsh & Partners, Keras Resources
Tuesday 26 July
Trading statements
Aberforth Smaller Companies Trust, Ascential, Bytes Technology, Capital & Counties Properties, Cohort, Compass, Drax, easyJet, Ergomed, Franchise Brands, Games Workshop, Gore Street Energy Storage Fund, Greencore, John Menzies, Medica, Mitie, NewRiver REIT, Playtech, Reach, Ricardo, Sabre Insurance, SME Credit Realisation Fund, Trifast, Tyman, Unilever, Vivo Energy, Wickes
AGM/EGM
AO World, Bytes Technology, Dekel Agri-Vision, Firering Strategic Minerals, Mitie, Momentum Multi-Asset Value Trust, nanosynth, NewRiver REIT, Ninety One, OnTheMarket, OptiBiotix Health, Telecom Plus, Vodafone, Xeros Technology
Wednesday 27 July
Trading statements
Aptitude Software, Aston Martin Lagonda Global Holdings, BlackRock Energy & Resources Income Trust, Breedon Group, British American Tobacco, FirstGroup, Fresnillo, GSK, Hargreaves Services, Hiscox, Ibstock, International Personal Financ, Lancashire Holdings, Lloyds Banking Group (LSE:LLOY), Marston's, Motorpoint, musicMagpie, Nichols, Primary Health Properties, Quartix Technologies, Reckitt Benckiser, Rio Tinto, Smart Metering Systems, Smurfit Kappa, Ted Baker, Unite Group, Wizz Air, Yourgene Health
AGM/EGM
Allied Minds, Caledonia Investments, De La Rue, FirstGroup, James Cropper, JPMorgan Japan Small Cap Growth & Income, Mode Global, Montanaro UK Smaller Cos Investment Trust, Motorpoint, Shield Therapeutics, Tatton Asset Management
- Model portfolio update: fund winners and losers in second quarter
- Three income tax traps that are a drag on building wealth
Thursday 28 July
Companies scheduled to begin trading without the right to the latest dividend include Royal Mail (LSE:RMG), SSE (LSE:SSE) and Moneysupermarket.com Group (LSE:MONY).
Trading statements
Airtel Africa, Anglo American, Aveva Group, BAE Systems, Barclays, Bodycote, BT Group (LSE:BT.A), Centrica (LSE:CNA), CVS Group, De La Rue, Diageo, discoverIE Group, Dr Martens, Elementis, FDM Group, Forterra, Foxtons, GB Group, Greencoat UK Wind, Hammerson, Headlam, Inchcape, Indivior, Informa, ITV, Jupiter Fund Management, Logistics Development, Metro Bank, Mitchells & Butlers, Mortgage Advice Bureau, Mothercare, MySale, National Express, Quixant, Rathbones, Relx, Rentokil Initial, Restore, Robert Walters, Schroders, Segro, Shell, Smith & Nephew, St James's Place, Vesuvius, Volex, Weir
AGM/EGM
B&M European Value Retail, Braemar Shipping Services, CMC Markets, CYBA, De La Rue, discoverIE Group, Eight Capital Partners, Eurasia Mining, GB Group, Global Smaller Companies Trust, Graft Polymer (UK), Ingenta, Mediclinic International, Octopus Renewables Infrastructure Trust, Oxford Instruments, RentGuarantor, Tate & Lyle, Ted Baker
Friday 29 July
Trading statements
AIB Group, Croda, Glencore, Harbourvest Global Private Equity, Industrials REIT, Intertek, Jupiter Fund Management, Morgan Advanced Materials, NatWest, Rightmove
AGM/EGM
Advanced Oncotherapy, Eneraqua Technologies, Palace Capital, Record, Tintra
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.